文献速递妇科

共享决策对子宫切除术后阿片类药物处方的影响

Effects of Shared Decision Making on Opioid Prescribing After Hysterectomy.
PubMed 文献 · Obstet Gynecol · 2019-01-01

本研究在学术机构开展前瞻性质量改进项目,纳入2018年3月1日至7月31日因良性非产科指征行子宫切除术的患者,使用可视化决策辅助工具进行统一教育并让患者自选出院阿片类药物片数。结果显示决策辅助实施后口服吗啡当量显著减少(92±35 vs 160±81,P<.01),再取药请求无显著变化,患者满意度和术后疼痛管理未受影响。

要点

  • 决策辅助实施后患者出院口服吗啡当量显著低于实施前(92±35 vs 160±81,P<.01)。
  • 决策辅助实施后76.6%患者选择的片数少于指南允许的最大量。
  • 再取药请求无显著变化(9.5% vs 5.7%,P=.15),约76%患者报告有剩余片剂。

核心结论

  • 该质量改进项目表明,简单的决策辅助工具可显著减少阿片类药物处方,同时不损害患者满意度或术后疼痛管理。

研究设计与样本

  • 前瞻性质量改进研究,纳入2018年3月1日至7月31日在本学术机构因良性非产科指征行子宫切除术的所有患者。
  • 170例符合条件患者中159例(93.5%)使用了决策辅助工具,其中110例(69.6%)腹腔镜、40例(25.3%)经阴道、8例(5.3%)开腹子宫切除术;1例使用决策辅助工具的患者因显著围手术期并发症被排除分析。
  • 术后14天进行结构化电话访谈,89.2%(n=141)参与者完成调查。

主要发现

  • 决策辅助实施后队列出院口服吗啡当量为92±35,决策辅助实施前队列为160±81,前者显著低于后者(P<.01)。
  • 再取药请求数量无显著变化:决策辅助实施后9.5%(n=15) vs 实施前5.7%(n=14),P=.15。
  • 决策辅助实施后队列中76.6%患者(n=121)选择的片数少于指南允许的最大量。
  • 约76%患者(n=102)报告有剩余片剂。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effects of shared decision making using a simple decision aid for opioid prescribing after hysterectomy. METHODS: We conducted a prospective quality initiative study including all patients undergoing hysterectomy for benign, nonobstetric indications between March 1, 2018, and July 31, 2018, at our academic institution. Using a visual decision aid, patients received uniform education regarding postoperative pain management. They were then educated on the department's guidelines regarding the maximum number of tablets recommended per prescription and the mean number of opioid tablets used by a similar cohort of patients in a previously published study at our institution. Patients were then asked to choose their desired number of tablets to receive on discharge. Structured telephone interviews were conducted 14 days after surgery. The primary outcome was total opioids prescribed before compared with after implementation of the decision aid. Secondary outcomes included opioid consumption, patient satisfaction, and refill requests after intervention implementation. RESULTS: Of 170 eligible patients, 159 (93.5%) used the decision aid (one patient who used the decision aid was subsequently excluded from the analysis owing to significant perioperative complications), including 110 (69.6%) laparoscopic, 40 (25.3%) vaginal, and eight (5.3%) abdominal hysterectomies. Telephone surveys were completed for 89.2% (n=141) of participants. Student's t-test showed that patients who participated in the decision aid (post-decision aid cohort) were discharged with significantly fewer oral morphine equivalents than patients who underwent hysterectomy before implementation of the decision aid (pre-decision aid cohort) (92±35 vs 160±81, P<.01), with no significant change in the number of requested refills (9.5% [n=15] vs 5.7% [n=14], P=.15). In the post-decision aid cohort, 76.6% of patients (n=121) chose fewer tablets than the guideline-allotted maximum. Approximately 76% of patients (n=102) reported having leftover tablets. CONCLUSION: This quality improvement initiative illustrates that a simple decision aid can result in a significant decrease in opioid prescribing without compromising patient satisfaction or postoperative pain management.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vilkins AL, Sahara M, Till SR, et al. Effects of Shared Decision Making on Opioid Prescribing After Hysterectomy. Obstet Gynecol. 2019. PMID: 31503160. doi:10.1097/AOG.0000000000003468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。